Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients-Reference-Cited by-同舟云学术

Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients

Published:2021-02 Issue:2 Volume:84 Page:233-241
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Yang Tzu-Han,Chou Chian-Ying,Yang Yi-Fan,Chien Chian-Shiu,Yarmishyn Aliaksandr A.,Yang Tzu-Ying,Liu Cheng-Hsuan,Chang Kao-Jung,Yang Yi-Ping,Chang Yuh-Lih

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. The outbreak of COVID-19: an overview.;Wu;J Chin Med Assoc,2020

2. Overview of coronavirus disease 2019 (COVID-19): treatment updates and advances.;Luo;J Chin Med Assoc,2020

3. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.;Siddiqi;J Heart Lung Transplant,2020

4. Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.;Wang;Cell Mol Immunol,2020

5. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.;Gautret;Int J Antimicrob Agents,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Widespread Use of Hydroxychloroquine Reduce the Transmissibility of SARS-CoV-2 / COVID-19? An Ecological Correlational Study;Infectious Disorders - Drug Targets;2023-12

2. THE EVOLUTION AND TREATMENT OPTIONS OF PATIENTS WITH COVID-19 AND NEUROLOGICAL MANIFESTATIONS – A NARRATIVE REVIEW;FARMACIA;2022-12-26

3. Comparing the effects of hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir on survival of geriatric population with COVID-19-related pneumonia: A propensity score-matched analysis;The Turkish Journal of Geriatrics;2022-03-31

4. Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials;BMJ Open;2022-03

5. Factors associated with mortality in patients hospitalized for COVID-19 in Spain. Data from the RERFAR registry;FARM HOSP;2022